GOP Presses RFK Jr on Mifepristone Review

0:00This is November 21st, 2025, news edition of the Let Freedom Podcast. Jeremy has some important development, so let's kick it over to our correspondent for a breakdown. Here's the news. Republicans are mounting a major push this week, urging HHS Secretary Robert F. Kennedy Jr. to reverse what they call the Biden administration's mistakes on the abortion pill drug mifepristone. At the heart of the effort, GOP senators and conservative health rights activists say that during the Biden years, the FDA loosened rules around access to mifepristone, especially via telehealth, in a way that compromised safety.

0:35Now they see Kennedy's request for a complete review of the drug's data as a chance to tighten oversight, restore stricter protocols, and potentially revise how the drug is dispensed. RFK Jr. has responded in kind. In a Senate hearing, he accused the previous administration of twisting the data on mifepristone, claiming they buried a safety signal showing nearly 11 percent of users experienced serious complications. He told lawmakers he's asked FDA Commissioner Marty Makari to conduct a top-to-bottom review to ensure more transparent, science-first decision-making going forward. That admission has energized Republicans.

1:14Over 50 GOP senators reportedly sent a coordinated letter to Kennedy demanding several changes, reinstating in-person dispensing requirements, limiting telemedicine access, and halting further generic approvals pending this review. They argue that without those changes, the Biden-era overcorrections will continue putting women's health at risk. For anti-abortion conservatives, this isn't a small policy tweak. It's a real opportunity. Kennedy, despite his Democratic roots, is now seen as someone who could roll back the very liberalization of Mifepristone that helped expand access under Biden. If he delivers, it could be framed as a win for both pro-life policy and stronger regulatory guardrails.

1:58But there's a tension for Kennedy, too. He has long claimed he views abortion as a tragedy, yet he also pledged to implement Trump's more restrictive policies on reproductive drugs. Now he's walking a tightrope, balancing the demands of conservative Republicans while trying not to alienate more moderate or pro-choice constituencies. If Kennedy follows through, the changes could reshape how abortion pills are regulated. Stricter dispensing could significantly limit access in many rural or underserved areas. Telehealth restrictions may roll back a major part of how people currently obtain the medication.

2:35And stopping new generic approvals could slow down price competition, with big implications for cost and availability. What to watch next? Will Kennedy publicly commit to the GOP's list of demands? Will FDA act on in-person requirements or reverse telehealth access? And how will pro-choice groups and women's health advocates respond if he moves to tighten the rules? Bottom line, Republicans see RFK Jr. as a crucial lever to undo parts of Biden-era abortion pill policy. For them, his commitment to reevaluate mifepristone is a rare alignment. For Kennedy, it's a politically charged moment, one where he must decide whether to take this chance to tighten rules, appease conservatives, or chart a new middle path.

3:20Thank you for listening to the Let Freedom Podcast, November 21st, 2025. Thank you for those important developments, Jeremy. And for our listeners, don't forget to tune in tomorrow for our full episode. Don't forget to rate us on Apple Podcasts, and we'll see you in the next one.